GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hikal Ltd (BOM:524735) » Definitions » Institutional Ownership

Hikal (BOM:524735) Institutional Ownership : 4.32% (As of Jun. 11, 2024)


View and export this data going back to 2000. Start your Free Trial

What is Hikal Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Hikal's institutional ownership is 4.32%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Hikal's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Hikal's Float Percentage Of Total Shares Outstanding is 0.00%.


Hikal Institutional Ownership Historical Data

The historical data trend for Hikal's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hikal Institutional Ownership Chart

Hikal Historical Data

The historical data trend for Hikal can be seen below:

2023-08-31 2023-09-30 2023-10-31 2023-11-30 2023-12-31 2024-01-31 2024-02-29 2024-03-31 2024-04-30 2024-05-31
Institutional Ownership 3.98 3.96 3.91 4.03 4.07 4.10 4.28 4.63 4.31 4.32

Hikal Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Hikal (BOM:524735) Business Description

Traded in Other Exchanges
Address
Great Eastern Chambers, 6th Floor, Sector 11, CBD Belapur, Navi Mumbai, MH, IND, 400 614
Hikal Ltd manufactures chemical intermediates, specialty chemicals, active pharma ingredients, and contract research activities. Its products are distributed to pharmaceuticals, biotech, agrochemicals, and specialty chemical industries. Its segments include crop protection and pharmaceuticals. The majority of the revenue is derived from the pharmaceutical segment.

Hikal (BOM:524735) Headlines

No Headlines